Cardiothoracic surgeon Timothy W. Mullett, medical director of the Markey Cancer Center Affiliate Network, was named chair of the Commission on Cancer of the American College of Surgeons.
Donna D. Zhang, of University of Arizona Health Sciences, has received an eight-year, $7.3 million grant from the National Institute of Environmental Health Sciences to determine how a family of proteins can be harnessed to prevent or treat arsenic-induced lung cancer and Type 2 diabetes.
The American Association for Cancer Research said its 2021 meeting will be virtual.
C. Ola Landgren was named director of the Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center of the University of Miami.
Neuro-oncologist Ingo K. Mellinghoff was appointed chair of the Department of Neurology at Memorial Sloan Kettering Cancer Center.
Beth Gaffney was named vice president of U.S. and Global Business Development at the National Clinical Trials Network.
The Reagan-Udall Foundation for the FDA has received $250,000 in funding from the Rockefeller Foundation to support the COVID-19 Diagnostics Evidence Accelerator launched earlier this year in collaboration with Friends of Cancer Research.
Global Cancer Institute has extended its programs to Bangladesh, with the launch of new monthly tumor boards that help physicians and oncologists in developing countries connect directly to U.S. physicians by videoconference to discuss challenging cancer cases and ask for advice.
Walter J. (Wally) Curran, Jr. said he would step down as executive director of Winship Cancer Institute of Emory University to serve as the global chief medical officer of GenesisCare, an international group described as “the world's largest provider of radiation oncology care and a major global provider of other medical services.”
Mark Bonnen was named chief medical officer at Mays Cancer Center at UT Health San Antonio.
